Myopia Control Effect of Continuous versus Sinusoidal Photobiomodulation Therapy in Children: A Randomized, Double-Blind, Controlled Clinical Trial

The world of childhood vision is facing a quiet crisis. Near-sightedness, or myopia, is no longer just a matter of needing glasses; it is a growing public health challenge where the eyeball itself grows too long. When an eye elongates excessively, it stretches the delicate tissues at the back, increasing the risk of serious vision problems later in life. For years, doctors have searched for ways to slow this stretching. One promising approach involves shining a specific type of red light into the eye, a technique known as photobiomodulation. The idea is that this light acts as a gentle signal to the eye's internal structures, perhaps encouraging them to stop growing as fast. However, as this therapy moves from the lab to the clinic, a new question has emerged: does the light need to shine constantly to work, or could a flickering, rhythmic pattern be just as effective? This question matters because constant light delivers a higher total dose of energy, raising concerns about safety, while a rhythmic pattern might achieve the same biological result with less overall exposure.

Researchers in Wuhan, China, set out to test this idea directly. They gathered a group of sixty-one children, aged six to twelve, who were either on the verge of becoming near-sighted or had just started to develop the condition. The team split these children into two groups, using a method that ensured neither the children nor the doctors knew which treatment was being used until the study ended. Both groups received treatment from the same device, which emitted a beam of red light with a wavelength of 650 nanometers. The only difference was how the light was delivered. One group received a steady, unbroken stream of light, while the other received a light that pulsed in a smooth, wave-like pattern, rising and falling in intensity. Crucially, the peak brightness of the light was identical for both groups, but the wave-like group received roughly half the total amount of light energy over the course of the treatment sessions. The children used these devices at home for three minutes, twice a day, for three months.

The scientists measured three key things to see how the eyes were reacting. First, they measured the length of the eyeball, known as axial length, because this is the primary indicator of myopia progression. Second, they checked the children's prescription strength to see if their vision was changing. Third, and perhaps most importantly for understanding how the light works, they measured the thickness of the choroid. The choroid is a layer of tissue rich in blood vessels that sits just behind the retina, and previous research suggested that when this layer thickens, it might signal that the eye is slowing down its growth.

After three months, the results showed a clear picture of what happened inside the eyes. Both groups of children experienced a slight increase in the length of their eyeballs, which is a normal occurrence for growing children. However, there was no meaningful difference between the group that received the steady light and the group that received the pulsing light. The eyes in both groups grew at almost the exact same rate. Similarly, the children's glasses prescriptions remained stable in both groups, with no significant difference in how their vision changed.

The most interesting finding appeared in the measurements of the choroid. In both groups, this layer of tissue became noticeably thicker within just one month of starting the treatment, and this thickening persisted through the three-month mark. The children receiving the pulsing, wave-like light actually showed slightly larger increases in choroidal thickness compared to those with the steady light, particularly in the very center of the eye. Yet, when the researchers ran the numbers to see if this difference was real or just a chance occurrence, the statistical evidence was not strong enough to declare one method superior to the other. The data suggested that the rhythmic light was capable of triggering the same early biological response as the constant light, even though it delivered less total energy, but the study was not designed to prove that one was definitively better than the other.

The study also looked closely for any signs that the treatment might be harming the children's eyes. The researchers examined the blood vessels in the retina and the optic nerve, checking for any damage or unusual changes. They found no evidence of injury. No child experienced severe side effects, and no one had to stop the treatment because of pain or discomfort. The eyes remained safe under both types of light exposure.

Ultimately, this research offers a glimpse into the future of how we might treat near-sightedness. It demonstrates that a rhythmic, lower-power light pattern can indeed trigger the early structural changes in the eye that are associated with myopia control. This is a significant step because it suggests that doctors might be able to design treatments that are gentler on the eye by using less total light energy, without losing the potential benefits. However, the study stops short of declaring a winner. It did not prove that the rhythmic light is better, nor did it prove that it is exactly the same as the steady light. It simply showed that the rhythmic approach is a viable path to explore. The researchers emphasize that more work is needed to understand the long-term effects and to determine the perfect balance of light intensity and timing. For now, the findings provide a solid foundation for refining these therapies, aiming to protect children's vision with the safest and most effective tools possible.